Association of vaspin gene polymorphisms with coronary artery disease in Chinese population and function study

被引:14
作者
Li, Hai Ling [1 ]
Zhang, Hong Li [2 ]
Jian, Wei Xia [3 ]
Li, Qi [1 ]
Peng, Wen Hui [1 ]
Xu, Ya Wei [1 ]
机构
[1] Tongji Univ, Dept Cardiol, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200072, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Inst Endocrinol, Dept Endocrinol, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Endocrinol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
Adipokine; Coronary artery disease; Vaspin; Polymorphism; VISCERAL ADIPOSE-TISSUE; SERINE-PROTEASE INHIBITOR; SERUM VASPIN; DIABETES-MELLITUS; ADIPOKINE VASPIN; ATHEROSCLEROSIS; ADIPOCYTOKINE; ADIPONECTIN; CONCOMITANT; IMPROVEMENT;
D O I
10.1016/j.cca.2012.10.042
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Visceral adipose tissue-derived serine protease inhibitor (vaspin) is a recently identified adipokine. Studies suggest it is involved in many diseases such as obesity, diabetes and coronary artery disease (CAD). This study is to investigate the association of single nucleotide polymorphisms (SNPs) in vaspin with CAD and its potential mechanisms. Methods: A total of 1570 consecutive patients undergoing coronary angiography were enrolled and the genotypes were determined by TaqMan allelic discrimination. Serum vaspin concentrations and mRNA expression levels were determined by ELISA and RT-PCR, respectively. Reporter gene assay was performed to investigate the effect of polymorphism on vaspin promoter function. Results: After multivariate analysis, allele A of rs2236242 was found as an independent determinant of CAD (OR=132, p=0.004). Rs35262691 in vaspin promoter was associated with serum vaspin concentration and mRNA expression in peripheral blood mononuclear cells (PBMC) though no association had been found with CAD. Reporter gene assay further confirmed that CC genotype of rs35262691 had 2.1 +/- 0.4-fold higher activities than TT genotype in facilitating gene expression. Conclusions: Our results show that the variants of vaspin gene are associated with serum vaspin levels and risk for CAD in Chinese population. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 40 条
  • [11] Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss
    Handisurya, Ammon
    Riedl, Michaela
    Vila, Greisa
    Maier, Christina
    Clodi, Martin
    Prikoszovich, Thomas
    Ludvik, Bernhard
    Prager, Gerhard
    Luger, Anton
    Kautzky-Willer, Alexandra
    [J]. OBESITY SURGERY, 2010, 20 (02) : 198 - 203
  • [12] Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity
    Hida, K
    Wada, J
    Eguchi, J
    Zhang, H
    Baba, M
    Seida, A
    Hashimoto, L
    Okada, T
    Yasuhara, A
    Nakatsuka, A
    Shikata, K
    Hourai, S
    Futami, J
    Watanabe, E
    Matsuki, Y
    Hiramatsu, R
    Akagi, S
    Makino, H
    Kanwar, YS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (30) : 10610 - 10615
  • [13] Circadian Rhythm of Serum Vaspin in Healthy Male Volunteers: Relation to Meals
    Jeong, Eunheui
    Youn, Byung-Soo
    Kim, Dong Woo
    Kim, Eun Hee
    Park, Ji Woo
    Namkoong, Churl
    Jeong, Ji Yun
    Yoon, So Yoon
    Park, Joong Yeol
    Lee, Ki-Up
    Kim, Min-Seon
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04) : 1869 - 1875
  • [14] Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway
    Jung, Chang Hee
    Lee, Woo Je
    Hwang, Jenie Yoonoo
    Seol, So Mi
    Kim, Yun Mi
    Lee, Yoo La
    Park, Joong-Yeol
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (02) : 264 - 269
  • [15] Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naive Patients with Type 2 Diabetes
    Kadoglou, N. P. E.
    Kapelouzou, A.
    Tsanikidis, H.
    Vitta, I.
    Liapis, C. D.
    Sailer, N.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (02) : 63 - 68
  • [16] Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk
    Kadoglou, Nikolaos P. E.
    Vrabas, Ioannis S.
    Kapelouzou, Alkistis
    Lampropoulos, Stylianos
    Sailer, Nikolaos
    Kostakis, Alkiviadis
    Liapis, Christos D.
    [J]. REGULATORY PEPTIDES, 2011, 170 (1-3) : 57 - 61
  • [17] Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study
    Kadoglou, Nikolaos P. E.
    Gkontopoulos, Argirios
    Kapelouzou, Alkistis
    Fotiadis, Grigorios
    Theofilogiannakos, Efstratios K.
    Kottas, George
    Lampropoulos, Stilianos
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (1-2) : 48 - 52
  • [18] Vaspin (SERPINA12) Genotypes and Risk of Type 2 Diabetes: Results from the MONICA/KORA studies
    Kempf, K.
    Rose, B.
    Illig, T.
    Rathmann, W.
    Strassburger, K.
    Thorand, B.
    Meisinger, C.
    Wichmann, H. -E.
    Herder, C.
    Vollmert, C.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (03) : 184 - 189
  • [19] Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations
    Kim, Seon Mee
    Cho, Geum Joo
    Yannakoulia, Mary
    Hwang, Taik Gun
    Kim, In Hee
    Park, Eun Kyung
    Mantzoros, Christos S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (09): : 1294 - 1299
  • [20] Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects
    Kloeting, N.
    Kovacs, P.
    Kern, M.
    Heiker, J. T.
    Fasshauer, M.
    Schoen, M. R.
    Stumvoll, M.
    Beck-Sickinger, A. G.
    Blueher, M.
    [J]. DIABETOLOGIA, 2011, 54 (07) : 1819 - 1823